Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00481741 · ClinicalTrials.gov registry record · Phase 4
Study of the SafeSeal(TM) Hemostasis Patch Following Percutaneous Coronary Artery and Peripheral Vascular Interventions
A Phase 4 study, sponsored by University of Rochester.
- Completed
- Registry status
- Phase 4
- Development phase
- 150
- Enrollment target
NCT00481741 is a Phase 4 study that has completed, run by University of Rochester. The registered enrollment target is 150 participants.
The verdict
NCT00481741, a Phase 4 study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 150 participants
- Enrollment target
Study Summary
We seek to determine if the use of the SafeSeal(TM) topical hemostasis patch is associated with reductions in time to hemostasis and time to ambulation compared to standard manual compression after arterial sheath removal following percutaneous coronary and peripheral intervention. We further seek to assess the safety of the SafeSeal patch compared to manual compression.
Interventions
- DEVICE SafeSeal(TM) Hemostasis Patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2007-05 |
| Est. Completion | 2007-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00481741
The ClinicalTrials.gov registry entry for NCT00481741 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SafeSeal(TM) Hemostasis Patch is the first listed.
NCT00481741 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00481741 about?
NCT00481741 is a clinical study titled "Study of the SafeSeal(TM) Hemostasis Patch Following Percutaneous Coronary Artery and Peripheral Vascular Interventions". We seek to determine if the use of the SafeSeal(TM) topical hemostasis patch is associated with reductions in time to hemostasis and time to ambulation compared to standard manual compression after arterial sheath removal following percutaneous coronary and peripheral intervention. We further seek t...
What is the current status of trial NCT00481741?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 150 participants. The study started on 2007-05. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00481741?
The interventions under investigation include: SafeSeal(TM) Hemostasis Patch (DEVICE).
Who is sponsoring clinical trial NCT00481741?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.